Hayk Saribekyan leads the engineering at Biosim Inc. Biosim’s mission is to reduce the timescale of drug discovery processes many-fold through its platform that combines cutting-edge ideas from scientific computing, AI and quantum chemistry. Biosim uses Julia across its technology stack to achieve state-of-the-art performance on its molecular dynamics and virtual screening tools, as well as to develop custom methods for its computational drug discovery pipeline.
Hayk has received a PhD in Computer Science from the University of Cambridge, where he was a Gates Scholar. Prior to that he received a BSc and MEng from MIT.
We have developed BiosimMD.jl, a package for performing molecular dynamics (MD) simulations significantly faster than state-of-the-art engines. We present performance benchmarks of the package and its versatility. The package allows scientists to implement novel methods for MD without compromising the speed of simulation. We also discuss aspects of Julia critical in BiosimMD’s development, including access to many levels of computational abstraction, metaprogramming, and ease of multi-threading.